Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors.

Fitzgerald, Jacklynn M; Chesney, Samantha A; Lee, Tara Sander; Brasel, Karen; Larson, Christine L; Hillard, Cecilia J; deRoon-Cassini, Terri A

Fitzgerald, Jacklynn M; Chesney, Samantha A; Lee, Tara Sander; Brasel, Karen; Larson, Christine L; Hillard, Cecilia J; deRoon-Cassini, Terri A.

Afiliação

Fitzgerald JM; Marquette University, Department of Psychology, Milwaukee, WI, USA.
Chesney SA; Froedtert Memorial Lutheran Hospital - Neurological Rehabilitation Services, Milwaukee, WI, USA.
Lee TS; Charlotte Lozier Institute, Arlington, VA, USA.
Brasel K; Oregon Health & Science University, Portland, OR, USA.
Larson CL; University of Wisconsin - Milwaukee, Department of Psychology, Milwaukee, WI, USA.
Hillard CJ; Medical College of Wisconsin, Neuroscience Research Center and Department of Pharmacology and Toxicology, Milwaukee, WI, USA.
deRoon-Cassini TA; Medical College of Wisconsin, Department of Surgery, Division of Trauma & Acute Care Surgery, Milwaukee, WI, USA.

Neurobiol Stress ; 14: 100304, 2021 May.

Article em En | MEDLINE | ID: mdl-33614866

Palavras-chave

Depression; Endocannabinoids; Genotype; Injuries; Trauma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neurobiol Stress Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google